The hemostatic system as a modulator of atherosclerosis

JI Borissoff, HMH Spronk… - New England Journal of …, 2011 - Mass Medical Soc
The Hemostatic System as a Modulator of Atherosclerosis | New England Journal of Medicine
Skip to main content The New England Journal of Medicine homepage Advanced Search …

Moving past anti-VEGF: novel therapies for treating diabetic retinopathy

MT Bolinger, DA Antonetti - International journal of molecular sciences, 2016 - mdpi.com
Diabetic retinopathy is the leading cause of blindness in working age adults, and is
projected to be a significant future health concern due to the rising incidence of diabetes …

Novel risk genes and mechanisms implicated by exome sequencing of 2572 individuals with pulmonary arterial hypertension

N Zhu, MW Pauciulo, CL Welch, KA Lutz… - Genome medicine, 2019 - Springer
Background Group 1 pulmonary arterial hypertension (PAH) is a rare disease with high
mortality despite recent therapeutic advances. Pathogenic remodeling of pulmonary …

[HTML][HTML] Defining the clinical validity of genes reported to cause pulmonary arterial hypertension

CL Welch, MA Aldred, S Balachandar, D Dooijes… - Genetics in …, 2023 - Elsevier
Purpose Pulmonary arterial hypertension (PAH) is a rare, progressive vasculopathy with
significant cardiopulmonary morbidity and mortality. Genetic testing is currently …

Early detection biomarkers for ovarian cancer

S Sarojini, A Tamir, H Lim, S Li, S Zhang… - Journal of …, 2012 - Wiley Online Library
Despite the widespread use of conventional and contemporary methods to detect ovarian
cancer development, ovarian cancer remains a common and commonly fatal gynecological …

Vitamin B1 analog benfotiamine prevents diabetes-induced diastolic dysfunction and heart failure through Akt/Pim-1–mediated survival pathway

RG Katare, A Caporali, A Oikawa, M Meloni… - Circulation: Heart …, 2010 - Am Heart Assoc
Background—The increasing incidence of diabetes mellitus will result in a new epidemic of
heart failure unless novel treatments able to halt diabetic cardiomyopathy early in its course …

The kinin–kallikrein system: physiological roles, pathophysiology and its relationship to cancer biomarkers

E Kashuba, J Bailey, D Allsup, L Cawkwell - Biomarkers, 2013 - Taylor & Francis
The kinin–kallikrein system (KKS) is an endogenous multiprotein cascade, the activation of
which leads to triggering of the intrinsic coagulation pathway and enzymatic hydrolysis of …

Kallikrein-related peptidases (KLKs) and the hallmarks of cancer

PS Filippou, GS Karagiannis, N Musrap… - Critical reviews in …, 2016 - Taylor & Francis
The kallikrein-related peptidases (KLKs) represent the largest family of serine proteases
within the human genome and are expressed in various tissues. Although they regulate …

Involvement of phosphoinositide 3-kinase γ in angiogenesis and healing of experimental myocardial infarction in mice

M Siragusa, R Katare, M Meloni, F Damilano… - Circulation …, 2010 - Am Heart Assoc
Rationale: Phosphoinositide 3-kinase (PI3K) γ is expressed in hematopoietic cells,
endothelial cells (ECs), and cardiomyocytes and regulates different cellular functions …

Involvement of kallikrein‐related peptidases in normal and pathologic processes

ACB Stefanini, BR da Cunha, T Henrique… - Disease …, 2015 - Wiley Online Library
Human kallikrein‐related peptidases (KLKs) are a subgroup of serine proteases that
participate in proteolytic pathways and control protein levels in normal physiology as well as …